By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Achilles Therapeutics 



London      United Kingdom
Phone: n/a Fax: n/a


SEARCH JOBS

Achilles intends to develop next-generation personalized vaccines and adoptive T cell therapies for metastatic cancer by targeting truncal tumor neoantigens. The company is based on research at University College London, Cancer Research UK (CRUK) and the Francis Crick Institute.

YEAR FOUNDED:

2016

LEADERSHIP:

Scientific Founder: Charles Swanton

CEO: Chris Ashton


Key Statistics


Email:
Ownership: Private

Web Site: Achilles
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->